FDA Finds Potential Carcinogen In Zantac Heartburn Drug; State Class Action Filed

(September 18, 2019, 9:04 AM EDT) -- SAN JOSE, Calif. — On the same day the Food and Drug Administration said it found the suspected carcinogen N-nitrosodimethylamine (NDMA) in the heartburn drug Zantac, four plaintiffs filed a class...
To view the full article, register now.